Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020. | JAMA Netw Open;4(3): e211552, 2021 03 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020.

Stout, Robert L; Rigatti, Steven J.

Affiliation

Stout RL; Clinical Reference Laboratory Inc, Lenexa, Kansas.
Rigatti SJ; Clinical Reference Laboratory Inc, Lenexa, Kansas.

JAMA Netw Open ; 4(3): e211552, 2021 03 01.

Article in En | MEDLINE | ID: mdl-33724387

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Seroepidemiologic Studies / Health Personnel / Asymptomatic Diseases / Pandemics / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: JAMA Netw Open Year: 2021 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Seroepidemiologic Studies / Health Personnel / Asymptomatic Diseases / Pandemics / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: JAMA Netw Open Year: 2021 Document type: Article